Tactile Systems Technology, Inc.
TCMDStock
$29.41+196.07%52W
Market Cap$648.72M
P/E33.99x
Div yield—
Beta0.81
Price Chart
Favorite Metrics
Price vs S&P 500 (26W)-15.47%
Price vs S&P 500 (4W)7.61%
VGM Score69.78
Market Capitalization$648.72M
P/E Ratio (Annual)33.99x
Earnings Surprise History
Q1 26-0.08est. -0.10
Analyst Recommendations
Apr 2026
May 2026
Jun 2026
Jul 2026
4.18
4.18
4.27
4.27
Industry Peers — Surgical & Medical Instruments(141)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
TCMDTactile Systems Technology, Inc. | B | B | B | $29.41 |
| SYKStryker Corporation | C | C | D | $331.20 |
| MMM3M Company | C | F | B | $161.77 |
| BSXBoston Scientific Corp. | C | B | F | $44.62 |
| MDLNMedline Inc. Class A common stock | C | D | D | $41.11 |
| BDXBecton, Dickinson and Co. | B | C | B | $159.93 |
| DXCMDexCom, Inc. | C | B | C | $77.98 |
| RMDResMed Inc. | C | B | D | $202.76 |
| WSTWest Pharmaceutical Services, Inc. | D | C | A | $362.44 |
| SOLVSolventum Corporation | C | D | B | $81.70 |
| PENPenumbra, Inc. | F | C | B | $319.60 |
About
Tactile Systems Technology develops home-based medical devices for chronic disease management. The company's proprietary platforms include FlexiTouch for lymphedema treatment and AcuTouch for chronic venous insufficiency, along with additional solutions for chronic swelling. These wearable and home-based therapies enable patients to manage their conditions outside clinical settings.